Anaerobic 90Y- and 177Lu-labeling of a DOTA-conjugated nonpeptide vitronectin receptor antagonist.
D001710:Biotin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics; D001839:Bombesin / Q000737:chemistry / Q000493:pharmacokinetics; D039302:Integrin alphaVbeta3 / Q000037:antagonists & inhibitors*; D008187:Lutetium / Q000737:chemistry* / Q000493:pharmacokinetics; D009942:Organometallic Compounds / Q000737:chemistry / Q000493:pharmacokinetics; D010446:Peptide Fragments / Q000737:chemistry / Q000493:pharmacokinetics; D011868:Radioisotopes / Q000737:chemistry* / Q000493:pharmacokinetics; D013678:Technology, Pharmaceutical / Q000379:methods; D015021:Yttrium Radioisotopes / Q000737:chemistry* / Q000493:pharmacokinetics
C478093:177Lu-DOTA-8-aminooctanoylbombesin (7-14)-amide; C405616:DOTA-biotin; D039302:Integrin alphaVbeta3; D009942:Organometallic Compounds; D010446:Peptide Fragments; D011868:Radioisotopes; D015021:Yttrium Radioisotopes; D008187:Lutetium; D001710:Biotin; D001839:Bombesin